This partnership represents a systemic shift from awareness to large-scale action for 57 lakh children
The program provides pharmaceutical manufacturers with auditable, primary emissions data and verified proof of a 30% CO? reduction across DFE Pharma’s lactose portfolio
Profitability metrics showed a sharper upward trend. Gross margin expanded 280 basis points to 61.2%
Granules India has reported total income of Rs. 1,384.29 crore during the period ended December 31, 2025
WuXi Biologics has integrated sustainability principles throughout its supplier lifecycle management
With US$ 30.46 billion in exports and robust manufacturing capabilities, the industry is poised to expand into high-value drugs while strengthening ESG and compliance standards
Enabling a new era in minimally invasive obesity treatment across Europe
The event will be attended by 35,000+ industry professionals
New offering to debut at the 32nd ESGCT Congress, October 7–10, 2025, in Seville, Spain
Mangalam Drugs and Organics receives repeat export order worth $ 21, 81,040
Subscribe To Our Newsletter & Stay Updated
